XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses        
Research and development $ 19,270 $ 16,747 $ 59,400 $ 42,192
General and administrative 4,656 2,865 12,860 7,392
Total operating expenses 23,926 19,612 72,260 49,584
Loss from operations (23,926) (19,612) (72,260) (49,584)
Interest and other income, net 2,308 1,470 7,351 3,248
Net loss (21,618) (18,142) (64,909) (46,336)
Unrealized gain on marketable securities 143 121 99 46
Total other comprehensive income 143 121 99 46
Total comprehensive loss (21,475) (18,021) (64,810) (46,290)
Net loss attributable to common stockholders $ (21,618) $ (18,142) $ (64,909) $ (46,336)
Net loss per common share, basic $ (0.63) $ (2.78) $ (1.93) $ (15.42)
Net loss per common share, diluted $ (0.63) $ (2.78) $ (1.93) $ (15.42)
Weighted average number of common shares outstanding used in computation of net loss per common share, basic 34,198,597 6,515,616 33,688,669 3,004,382
Weighted average number of common shares outstanding used in computation of net loss per common share, diluted 34,198,597 6,515,616 33,688,669 3,004,382